Danoprevir

CAS NO.：850876-88-9
Empirical Formula: C35H46FN5O9S
Molecular Weight: 731.83
MDL number: MFCD16038038
SAFETY DATA SHEET (SDS)
Update Date: 2026-07-27 17:00:41

What is Danoprevir?

Description

Danoprevir is an orally bioavailable inhibitor of hepatitis C virus (HCV) nonstructural protein 3/4A (NS3/4A; IC₅₀ = 1 nM), a serine protease essential for HCV replication. It is selective for NS3/4A over a panel of 53 proteases at a concentration of 10 μM. Danoprevir inhibits replication of the HCV genotypes 1a, 1b, 4, 5, and 6 (IC₅₀s = 0.2-0.4 nM) as well as 2b and 3a (IC₅₀s = 1.6 and 3.5 nM, respectively) in vitro. It also reduces the number of HCV genotype 1b replicons in Huh-7 cells (EC₅₀ = 1.8 nM).

The Uses of Danoprevir

Danoprevir is a selective and potent inhibitor of Hepatitis C virus.

What are the applications of Application

Danoprevir is an inhibitor of the NS3/4A protease of hepatitis C virus (HCV)

Properties of Danoprevir

Melting point:	>165°C (dec.)
Density	1.41
storage temp.	-20°C Freezer
solubility	Acetone (Slightly), DMSO (Slightly), Methanol (Slightly)
form	Solid
pka	4.43±0.60(Predicted)
color	White to Pale Beige

Safety information for Danoprevir

Signal word	Warning
Pictogram(s)	Exclamation Mark Irritant GHS07
GHS Hazard Statements	H302:Acute toxicity,oral
Precautionary Statement Codes	P280:Wear protective gloves/protective clothing/eye protection/face protection. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

Computed Descriptors for Danoprevir

InChIKey	ZVTDLPBHTSMEJZ-AIYSODCISA-N
SMILES	C1C2=C(C(F)=CC=C2)CN1C(O[C@H]1CN2C(=O)[C@@H](NC(OC(C)(C)C)=O)CCCCCC=C[C@]3([H])C[C@@]3(C(NS(C3CC3)(=O)=O)=O)NC(=O)[C@]2([H])C1)=O \|t:33\|